Neil Woodford's £736m Patient Capital trust saw a much-needed pick-up in performance in 2018 as a number of its success stories, many of which are unlisted companies, are "gradually beginning to account for a larger portion of assets".
In its final results for the 12 months to 31 December, released this morning, the board revealed many of the trust's unquoted holdings - which represent 65% of the portfolio - saw significant progression over the year. In turn, this contributed to the trust's net asset value (NAV) increasing 6.9% from 91.33p to 97.61p over the year. Is a 'spectacular' rebound on the cards for Woodford in 2019? Woodford said: "We have been pleased with the operational progress being delivered by the majority of companies in the portfolio. "The portfolio's success stories are gradually beginning t...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
